AFG
ABBV icon

Atomi Financial Group’s AbbVie ABBV Stock Holding History

Atomi Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$31.4M Buy
124,737
+81,138
+186% +$17.5M 0.82% 26
2026
Q1 		$9.48M Sell
43,599
-742
-2% -$165K 0.29% 67
2025
Q4 		$10.1M Buy
44,341
+25,534
+136% +$5.82M 0.3% 62
2025
Q3 		$4.35M Buy
18,807
+3,853
+26% +$785K 0.14% 117
2025
Q2 		$2.78M Sell
14,954
-2,185
-13% -$406K 0.1% 142
2025
Q1 		$3.59M Buy
17,139
+2,644
+18% +$514K 0.16% 104
2024
Q4 		$2.58M Buy
14,495
+2,122
+17% +$390K 0.13% 121
2024
Q3 		$2.44M Buy
12,373
+516
+4% +$96.3K 0.15% 112
2024
Q2 		$2.03M Sell
11,857
-1,190
-9% -$197K 0.15% 119
2024
Q1 		$2.38M Buy
13,047
+830
+7% +$143K 0.22% 98
2023
Q4 		$1.89M Buy
12,217
+3,667
+43% +$535K 0.26% 80
2023
Q3 		$1.27M Sell
8,550
-258
-3% -$37.9K 0.43% 60
2023
Q2 		$1.19M Buy
8,808
+77
+0.9% +$11.3K 0.54% 45
2023
Q1 		$1.39M Buy
+8,731
New +$1.33M 0.78% 27

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Atomi Financial Group's ABBV Position: Q2 2026 in Review

Atomi Financial Group increased its AbbVie (ABBV) stake by 186% in Q2 2026, buying an estimated $17.5M and bringing the position to 124,737 shares worth $31.4M. The position accounts for 0.82% of the portfolio, ranked #26.

Atomi Financial Group first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,192 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Atomi Financial Group held 124,737 shares of AbbVie worth $31.4M as of Q2 2026.
  • Atomi Financial Group bought 81,138 AbbVie shares in Q2 2026, an estimated $17.5M.
  • AbbVie made up 0.82% of Atomi Financial Group's portfolio in Q2 2026, its #26 holding.
  • Atomi Financial Group first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,192 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.